Marvell trades at 77.4 times earnings as SK hynix's first commercial memory runs on a startup's chip
At the Open Compute Project summit, SK hynix put its first named commercial CXL memory product on a startup's compute-in-memory chip, due for mass production before Marvell's rival expander samples. Marvell still trades at 77.4 times trailing earnings on a fiscal 2028 outlook management just raised to $20 billion.
Vincent Jiang · 3 min read
SK hynix−0.81% — SK hynix, down 0.81 percent today, the world's second-largest DRAM maker, spent the Open Compute Project summit in San Jose this month showing CXL Hybrid Memory, its first named commercial product on CXL, the interconnect that pools server memory. The controller inside came from XCENA, a startup founded in 2022 by Samsung and SK hynix veterans, not from Marvell+1.60% — Marvell, up 1.60 percent today 1.
Marvell has priced that link for investors. It sizes the market for silicon connecting AI chips at $37 billion, its own estimate relayed through MarketBeat 2, and LightCounting founder Vladimir Kozlov puts AI scale-up networking above $50 billion by 2030 3.
Marvell papered the rack in one week
On October 12 it announced second-generation Structera X memory expanders carrying up to 9 terabytes per controller 4. On October 13 came the Alaska E 3.2T retimer, 16 lanes of 224G signaling, and a 3nm Alaska A 1.6T cable DSP drawing 12.8 watts, both already sampling 3. On October 19 it co-founded an OCP security group with Microsoft−0.34% — Microsoft, down 0.34 percent today and Oracle+2.82% — Oracle, up 2.82 percent today 5. At its October 6 investor day, management raised its fiscal 2028 revenue outlook to about $20 billion, against $9.45 billion of trailing revenue, and set a fiscal 2031 target of $70 billion to $90 billion 6.
Ten straight quarters of revenue growth, to $2.74 billion in August
Data
| Revenue | |
|---|---|
| Q3 '23 | $1.42B |
| Q4 '23 | $1.43B |
| Q1 '24 | $1.16B |
| Q2 '24 | $1.27B |
| Q3 '24 | $1.52B |
| Q4 '24 | $1.82B |
| Q1 '25 | $1.9B |
| Q2 '25 | $2.01B |
| Q3 '25 | $2.08B |
| Q4 '25 | $2.22B |
| Q1 '26 | $2.42B |
| Q2 '26 | $2.74B |
Compute moved inside the memory
Structera X makes memory bigger; the host processor still does the thinking. XCENA's MX1 puts 3,072 RISC-V cores inside the controller, and at Hot Chips 2026 it measured up to 4.7 times a host CPU's throughput over CXL at 18.7 times the energy efficiency, on 40 watts 1. Samsung starts MX1 mass production on its foundry lines by year-end, with revenue from 2027 1. Marvell's second-generation expander samples in the first quarter of 2027 4. The rival chip reaches production before Marvell's answer takes its first sample.
The DRAM makers hedged: Samsung and SK hynix both supplied endorsement quotes for the Structera launch even as they backed the startup 4. And on October 14 two accounts posted that Marvell's OCP booth showed "significant levels of cheating": waveform averaging used for an eye measurement, a TDECQ reading flagged with a question mark, an RLM of 0.9 against a 0.95 spec 89. The claims are unverified, and no Marvell response appears in the coverage gathered.
The bill arrives in 2028
A KeyBanc note relayed on X on October 19 has Marvell likely to win Microsoft's Maia, the in-house AI accelerator, over MediaTek and Broadcom+1.36% — Broadcom, up 1.36 percent today for the Maia 400 generation 10. Maia 300 enters production in the first half of 2027 at roughly 500,000 units; Maia 400 ramps in the first half of 2028 10. A sector table posted the same day puts Marvell at 40 times forward earnings, against 17 for Nvidia+0.32% — Nvidia, up 0.32 percent today and 5 for Micron+1.26% — Micron, up 1.26 percent today 11. The shares fell 17.2% across the five sessions to October 16 and still closed at 77.4 times trailing earnings 6.
Marvell's 40x forward earnings trails only AMD and Intel
Data
| Value | |
|---|---|
| Micron | 5x |
| Nvidia | 17x |
| Qualcomm | 18x |
| TSMC | 18x |
| Broadcom | 19x |
| ASML | 26x |
| Marvell | 40x |
| AMD | 47x |
| Intel | 52x |
Three dates settle it: XCENA on Samsung's production lines by year-end 1, Marvell's Structera sampling in the first quarter of 2027 4, and the report against a $3.15 billion quarterly guide due around November 30 6. Nothing in the Maia thesis collects revenue before 2028 10.
Deepdive
AI-generated from this story and its cited sources. Not investment advice.



